IGF-1 splice variant injected at the working muscle for localised growth.
Typical dose range: 100–200 mcg
Frequency: Post-workout
Route: Intramuscular (site)
Half-life: Minutes
Evidence level: Pre-clinical
Site-specific use only — systemic dosing isn't useful given the very short half-life.